🇮🇳IN
Sign In
RE

REMUS

NSE

REMUS PHARMACEUTICALS L

₹901.20

-14.55(-1.59%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

REMUS valuation summary

REMUS PHARMACEUTICALS L trades at 42.0 times trailing earnings. Return on equity is 8.7% and return on capital employed is 11.7%. The dividend yield is 0.06%.

P/E42.0
ROE8.7%
ROCE11.7%
Dividend yield0.06%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer